Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01118416 · ClinicalTrials.gov registry record · NA
Risk Reduction Intervention for Vulnerable Young Adult Males
A NA study of HIV and Substance Use, sponsored by Hunter College of City University of New York.
- Completed
- Registry status
- NA
- Development phase
- 317
- Enrollment target
- 1
- Study location
NCT01118416: Completed NA study of HIV and Substance Use, sponsored by Hunter College of City University of New York.
NCT01118416 is a NA study of HIV and Substance Use that has completed, run by Hunter College of City University of New York. The registered enrollment target is 317 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01118416, a NA study of HIV and Substance Use, has completed, sponsored by Hunter College of City University of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 317 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this study is to test a brief 4-session risk reduction intervention, based on Motivational Enhancement Therapy (MET) to reduce the co-occurrence of club drug use and sexual risk taking behaviors among non-treatment seeking young men who have sex with men (YMSM) in NYC.
Primary Outcome
Participants in the MET condition will report greater reductions in the number of unprotected anal intercourse acts and in the proportion of days of club drug use than those in the education comparison condition at the end of the intervention period (3 months) and will maintain greater reductions in the number of unprotected anal intercourse acts and the proportion of days of club drug use than those in the education comparison condition at the three follow-up assessments (6, 9, and 12 months).
Conditions Studied
Interventions
- BEHAVIORAL HIV prevention intervention randomized control trial
Study Locations (1)
New York
- Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 317 participants |
| Start Date | 2006-06 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT01118416 record still lists
NCT01118416 is an interventional study that assigns participants to a tested intervention. The registered 317 participants enrollment target is mid-sized for trials with a published cap, below the 439-participant average among 303 other HIV trials with a reported enrollment target (28% lower).
The record links to 3 conditions, with HIV appearing as the primary indexed condition, and to 1 intervention - of which HIV prevention intervention randomized control trial is the first listed.
NCT01118416 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01118416 about?
NCT01118416 is a clinical study titled "Risk Reduction Intervention for Vulnerable Young Adult Males". The primary aim of this study is to test a brief 4-session risk reduction intervention, based on Motivational Enhancement Therapy (MET) to reduce the co-occurrence of club drug use and sexual risk taking behaviors among non-treatment seeking young men who have sex with men (YMSM) in NYC.
What is the current status of trial NCT01118416?
This trial is currently completed. It is a NA study. The enrollment target is 317 participants. The study started on 2006-06. Estimated completion is 2011-10.
What conditions does trial NCT01118416 study?
This clinical trial studies the following conditions: HIV, Substance Use, Sex.
What interventions are being tested in trial NCT01118416?
The interventions under investigation include: HIV prevention intervention randomized control trial (BEHAVIORAL).
Who is sponsoring clinical trial NCT01118416?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01118416 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01118416's enrollment target sits among peer trials
317 67th of 303 higher than 237 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04594642 · 317 participants · Phase 1
A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma
- NCT04977453 · 317 participants · Phase 1
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
- NCT05137054 · 317 participants · Phase 1
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- NCT05382754 · 317 participants · NA
Home Apnea Testing in CHildren Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia